Keywords
Last Name
Institution

Rita Munn Kramer

Title
InstitutionMedical University of South Carolina
DepartmentHematology/Oncology
AddressP.O. Box MSC 635
102
173 Ashley Ave.
Phone843-792-4271
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Cancer, Cancer/Breast, Vitamin D

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Walter KR, Ford ME, Gregoski MJ, Kramer RM, Knight KD, Spruill L, Nogueira LM, Krisanits BA, Phan V, La Rue AC, Lilly MB, Ambs S, Chan K, Turner TF, Varner H, Singh S, Uribarri J, Garrett-Mayer E, Armeson KE, Hilton EJ, Clair MJ, Taylor MH, Abbott AM, Findlay VJ, Peterson LL, Magwood G, Turner DP. Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571. PMID: 30368741.
      View in: PubMed
    2. Bea VJ, Cunningham JE, Alberg AJ, Burshell D, Bauza CE, Knight KD, Hazelton TR, Varner H, Kramer R, Bolick S, Hurley D, Mosley C, Ford ME. Alcohol and Tobacco Use in an Ethnically Diverse Sample of Breast Cancer Patients, Including Sea Island African Americans: Implications for Survivorship. Front Oncol. 2018; 8:392. PMID: 30319964.
      View in: PubMed
    3. Kramer R, Bielawski J, Kistner-Griffin E, Othman A, Alecu I, Ernst D, Kornhauser D, Hornemann T, Spassieva S. Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy. FASEB J. 2015 Nov; 29(11):4461-72. PMID: 26198449.
      View in: PubMed
    4. Wu MF, Hilsenbeck SG, Tham YL, Kramer R, Elledge RM, Chang JC, Friedman LC. The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer. Breast Cancer Res Treat. 2009 Nov; 118(2):369-75. PMID: 19495957.
      View in: PubMed
    5. Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol. 2007 Apr; 30(2):126-32. PMID: 17414460.
      View in: PubMed
    6. Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer. 2006 Aug 15; 107(4):696-704. PMID: 16826579.
      View in: PubMed
    7. Tham YL, Sexton K, Weiss HL, Elledge RM, Friedman LC, Kramer RM. The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause. J Support Oncol. 2006 Jun; 4(6):295-8, 304. PMID: 16805332.
      View in: PubMed
    8. Friedman LC, Kramer RM. Reproductive issues for women with BRCA mutations. J Natl Cancer Inst Monogr. 2005; (34):83-6. PMID: 15784831.
      View in: PubMed
    9. Kramer R. 26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on clinical research. Breast Cancer Res. 2004; 6(2):84-7. PMID: 14979912.
      View in: PubMed
    10. Kramer R, Brown P. Should tamoxifen be used in breast cancer prevention? Drug Saf. 2004; 27(13):979-89. PMID: 15471505.
      View in: PubMed
    Kramer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description